178 related articles for article (PubMed ID: 22684926)
1. Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.
Warsch S; Hosein PJ; Morris MI; Teomete U; Benveniste R; Chapman JR; Lossos IS
Int J Hematol; 2012 Aug; 96(2):274-8. PubMed ID: 22684926
[TBL] [Abstract][Full Text] [Related]
2. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
[TBL] [Abstract][Full Text] [Related]
3. [Recommendation for the optimal use of bendamustine in Japan].
Ohmachi K; Maruyama D; Nisikori M; Suzuki T; Izutsu K
Rinsho Ketsueki; 2014 Mar; 55(3):311-20. PubMed ID: 24681934
[No Abstract] [Full Text] [Related]
4. Progressive multifocal leukoencephalopathy in the course of combined therapy with bendamustine and rituximab.
Rosas Cancio-Suárez M; Barbolla Díaz I; González-García A
Med Clin (Barc); 2020 Dec; 155(11):513-514. PubMed ID: 31492452
[No Abstract] [Full Text] [Related]
5. An evaluation of the potential for drug-drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Darwish M; Burke JM; Hellriegel E; Robertson P; Phillips L; Ludwig E; Munteanu MC; Bond M
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1119-27. PubMed ID: 24677018
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.
Lucijanic M; Jaksic O
Ann Hematol; 2020 Sep; 99(9):2191-2192. PubMed ID: 32556456
[No Abstract] [Full Text] [Related]
7. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
[TBL] [Abstract][Full Text] [Related]
8. The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.
Friedberg JW; Vose JM; Kelly JL; Young F; Bernstein SH; Peterson D; Rich L; Blumel S; Proia NK; Liesveld J; Fisher RI; Armitage JO; Grant S; Leonard JP
Blood; 2011 Mar; 117(10):2807-12. PubMed ID: 21239695
[TBL] [Abstract][Full Text] [Related]
9. High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Weide R; Hess G; Köppler H; Heymanns J; Thomalla J; Aldaoud A; Losem C; Schmitz S; Haak U; Huber C; Unterhalt M; Hiddemann W; Dreyling M;
Leuk Lymphoma; 2007 Jul; 48(7):1299-306. PubMed ID: 17613757
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia.
Herold T; Seiler T; Egensperger R; Trumm C; Bergmann M; Franke D; Mumm FF; Schinwald N; Buske C; Dreyling M
Leuk Lymphoma; 2012 Jan; 53(1):169-72. PubMed ID: 21812535
[No Abstract] [Full Text] [Related]
11. Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
Waldthaler C; Stauder R; Schnallinger M; Schreieck S; Hager J; Oexle H; Zangerl G; Verdorfer I; Zabernigg A; Gastl G; Fiegl M
Wien Klin Wochenschr; 2011 May; 123(9-10):269-75. PubMed ID: 21479652
[TBL] [Abstract][Full Text] [Related]
12. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
Carter SJ; Bernstein SH; Friedberg JW; Barr PM
Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
[No Abstract] [Full Text] [Related]
14. Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab.
Bonavita S; Conforti R; Russo A; Sacco R; Tessitore A; Gallo A; Della Corte M; Monsurrò MR; Tedeschi G
Neurol Sci; 2008 Feb; 29(1):37-9. PubMed ID: 18379739
[TBL] [Abstract][Full Text] [Related]
15. Cryoglobulins mimicking platelet recovery in a mantle cell lymphoma patient treated with chemoimmunotherapy.
Herishanu Y; Katz BZ
Blood; 2015 Feb; 125(6):1047. PubMed ID: 25802907
[No Abstract] [Full Text] [Related]
16. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.
Hess G; Keller U; Scholz CW; Witzens-Harig M; Atta J; Buske C; Kirschey S; Ruckes C; Medler C; van Oordt C; Klapper W; Theobald M; Dreyling M
Leukemia; 2015 Aug; 29(8):1695-701. PubMed ID: 25765545
[TBL] [Abstract][Full Text] [Related]
18. Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximab.
Kourelis TV; Kahl BS; Benn P; Delach JA; Bilgrami SF
Acta Haematol; 2011; 126(1):40-3. PubMed ID: 21430370
[TBL] [Abstract][Full Text] [Related]
19. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab.
Rey J; Belmecheri N; Bouayed N; Ivanov V; Coso D; Gastaut JA; Bouabdallah R
Haematologica; 2007 Oct; 92(10):e101. PubMed ID: 18024364
[No Abstract] [Full Text] [Related]
20. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment.
Sano Y; Nakano Y; Omoto M; Takao M; Ikeda E; Oga A; Nakamichi K; Saijo M; Maoka T; Sano H; Kawai M; Kanda T
Intern Med; 2015; 54(8):965-70. PubMed ID: 25876582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
